Antibe Therapeutics Inc (ATE.TO)
0.295
0.00 (0.00%)
CAD |
TSX |
May 16, 16:00
Antibe Therapeutics Enterprise Value: -9.370M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | -9.370M |
| May 15, 2024 | -9.370M |
| May 14, 2024 | -9.370M |
| May 13, 2024 | -9.370M |
| May 10, 2024 | -9.370M |
| May 09, 2024 | -9.370M |
| May 08, 2024 | -9.370M |
| May 07, 2024 | -9.370M |
| May 06, 2024 | -9.370M |
| May 03, 2024 | -9.370M |
| May 02, 2024 | -9.370M |
| May 01, 2024 | -9.370M |
| April 30, 2024 | -9.370M |
| April 29, 2024 | -9.370M |
| April 26, 2024 | -9.370M |
| April 25, 2024 | -9.370M |
| April 24, 2024 | -9.370M |
| April 23, 2024 | -9.370M |
| April 22, 2024 | -9.370M |
| April 19, 2024 | -9.370M |
| April 18, 2024 | -9.370M |
| April 17, 2024 | -9.370M |
| April 16, 2024 | -9.370M |
| April 15, 2024 | -9.370M |
| April 12, 2024 | -9.370M |
| Date | Value |
|---|---|
| April 11, 2024 | -9.370M |
| April 10, 2024 | -9.370M |
| April 09, 2024 | -9.370M |
| April 08, 2024 | -9.370M |
| April 05, 2024 | -11.21M |
| April 04, 2024 | -9.370M |
| April 03, 2024 | -10.95M |
| April 02, 2024 | -15.16M |
| April 01, 2024 | -16.22M |
| March 28, 2024 | -1.207M |
| March 27, 2024 | -2.260M |
| March 26, 2024 | -1.997M |
| March 25, 2024 | -2.260M |
| March 22, 2024 | -2.523M |
| March 21, 2024 | -2.523M |
| March 20, 2024 | -3.576M |
| March 19, 2024 | -3.576M |
| March 18, 2024 | -2.523M |
| March 15, 2024 | -2.260M |
| March 14, 2024 | -0.9432M |
| March 13, 2024 | 0.1101M |
| March 12, 2024 | -0.6799M |
| March 11, 2024 | -2.523M |
| March 08, 2024 | -1.207M |
| March 07, 2024 | 2.48M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-27.47M
Minimum
Dec 15 2021
256.03M
Maximum
Feb 17 2021
52.64M
Average
10.55M
Median
Nov 23 2023
Enterprise Value Benchmarks
| Biocure Technology Inc | 1.448M |
| Core One Labs Inc | 8.808M |
| Nova Mentis Life Science Corp | 2.183M |
| Nanosphere Health Sciences Inc | 0.2445M |
| Lobe Sciences Ltd | 3.658M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.213M |
| Total Expenses (Quarterly) | 4.596M |
| EPS Diluted (Quarterly) | -0.08 |
| Earnings Yield | -118.6% |